For people coming off other GLP-1s (semaglutide or tirzepatide), you have some receptor adaptation already
We have to remember that during the first 1,000 days from conception to about 2 years of life there are many stages of development that only take place during a specific window of time
Negro R, Fallahi P, Ferrari SM, Antonelli A
Currently, in addition to LY3463251, several other GDF-15 agonists are being assessed in early-stage clinical trials, including NNC0247-0829 and JNJ-9090/CIN-109, among others
It directly affects whether the peptide works, whether it is safe and whether you have any recourse if something goes wrong
Are there any side effects when starting peptide therapy